SEC 13F Intelligence

Synovus Financial Corp / JNJ

Synovus Financial Corp’s Johnson & Johnson Position

Does Synovus Financial Corp own Johnson & Johnson (JNJ)? Yes — 230.2K shares worth $43M (+0.49% of its 13F portfolio) as of Q3 2025, up from 224.5K shares the prior filed quarter.

Position Value
$43M
Q3 2025
Shares
230.2K
% of Portfolio
+0.49%
Quarters Held
28
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $39MQ4 ’18Q1 ’19: $42MQ2 ’19: $42MQ3 ’19: $40MQ4 ’19: $44MQ4 ’19Q1 ’20: $46MQ2 ’20: $43MQ3 ’20: $45MQ4 ’20: $47MQ4 ’20Q1 ’21: $50MQ2 ’21: $49MQ3 ’21: $48MQ4 ’21: $51MQ4 ’21Q1 ’22: $50MQ2 ’22: $52MQ3 ’22: $49MQ4 ’22: $52MQ4 ’22Q1 ’23: $45MQ2 ’23: $49MQ3 ’23: $45MQ4 ’23: $42MQ4 ’23Q1 ’24: $42MQ2 ’24: $37MQ3 ’24: $39MQ4 ’24: $33MQ4 ’24Q1 ’25: $38MQ2 ’25: $34MQ3 ’25: $43Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025230.2K$43M+0.49%
Q2 2025224.5K$34M+0.42%
Q1 2025226.6K$38M+0.49%
Q4 2024226.9K$33M+0.42%
Q3 2024241.2K$39M+0.45%
Q2 2024255.6K$37M+0.49%
Q1 2024263.6K$42M+0.54%
Q4 2023266.7K$42M+0.59%
Q3 2023290.2K$45M+0.52%
Q2 2023294.0K$49M+0.53%
Q1 2023293.2K$45M+0.51%
Q4 2022295.6K$52M+0.60%
Q3 2022298.7K$49M+0.60%
Q2 2022294.8K$52M+0.61%
Q1 2022282.5K$50M+0.53%
Q4 2021300.9K$51M+0.51%
Q3 2021296.5K$48M+0.51%
Q2 2021298.6K$49M+0.49%
Q1 2021302.1K$50M+0.55%
Q4 2020299.2K$47M+0.54%
Q3 2020301.9K$45M+0.60%
Q2 2020303.8K$43M+0.62%
Q1 2020347.8K$46M+0.64%
Q4 2019302.6K$44M+0.60%
Q3 2019307.8K$40M+0.60%
Q2 2019304.5K$42M+0.63%
Q1 2019303.0K$42M+0.69%
Q4 2018301.1K$39M+0.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Synovus Financial Corp’s full portfolio or all institutional holders of JNJ.